Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kabashima

Showing results (691-700 of 796) with videos related to

Pageof 80
Sort By:
The Journal of Investigative Dermatology|September 24, 2021
CCL2‒CCR2 Signaling in the Skin Drives Surfactant-Induced Irritant Contact Dermatitis through IL-1β‒Mediated Neutrophil AccumulationRintaro Shibuya, Yoshihiro Ishida, Sho Hanakawa, et al.
The American Journal of Pathology|March 23, 2010
Flaky tail mouse denotes human atopic dermatitis in the steady state and by topical application with Dermatophagoides pteronyssinus extractCatharina Sagita Moniaga, Gyohei Egawa, Hiroshi Kawasaki, et al.
Allergy|April 2, 2024
Targeting IL-13 with tralokinumab normalizes type 2 inflammation in atopic dermatitis both early and at 2 yearsEmma Guttman-Yassky, Kenji Kabashima, Delphine Staumont-Salle, et al.
The Journal of Dermatology|May 13, 2015
Pathological characterization of pachydermia in pachydermoperiostosisKeiji Tanese, Hironori Niizeki, Atsuhito Seki, et al.
Cancer Science|September 12, 2019
Variable indoleamine 2,3-dioxygenase expression in acral/mucosal melanoma and its possible link to immunotherapyNatsuko Iga, Atsushi Otsuka, Masahiro Hirata, et al.
JAMA Dermatology|February 1, 2023
Efficacy and Safety of Dupilumab in Patients With Erythrodermic Atopic Dermatitis: A Post Hoc Analysis of 6 Randomized Clinical TrialsAmy S Paller, Jonathan I Silverberg, Michael J Cork, et al.
The Journal of Allergy and Clinical Immunology. in Practice|September 15, 2022
Magnitude and Time Course of Response to Abrocitinib for Moderate-to-Severe Atopic DermatitisKristian Reich, Peter A Lio, Robert Bissonnette, et al.
Plos One|April 14, 2021
Pollen-food allergy syndrome and component sensitization in adolescents: A Japanese population-based studyTomoyuki Kiguchi, Kiwako Yamamoto-Hanada, Mayako Saito-Abe, et al.
The Journal of Dermatology|February 3, 2025
Guidelines for the management of drug-induced hypersensitivity syndrome 2023Yoshiko Mizukawa, Natsumi Hama, Hiroyuki Niihara, et al.
Lancet (London, England)|May 23, 2021
Safety and efficacy of upadacitinib in combination with topical corticosteroids in adolescents and adults with moderate-to-severe atopic dermatitis (AD Up): results from a randomised, double-blind, placebo-controlled, phase 3 trialKristian Reich, Henrique D Teixeira, Marjolein de Bruin-Weller, et al.
Pageof 80

Showing results (691-700 of 796) with videos related to

Sort By:
Pageof 80
The Journal of Investigative Dermatology|September 24, 2021
CCL2‒CCR2 Signaling in the Skin Drives Surfactant-Induced Irritant Contact Dermatitis through IL-1β‒Mediated Neutrophil AccumulationRintaro Shibuya, Yoshihiro Ishida, Sho Hanakawa, et al.
The American Journal of Pathology|March 23, 2010
Flaky tail mouse denotes human atopic dermatitis in the steady state and by topical application with Dermatophagoides pteronyssinus extractCatharina Sagita Moniaga, Gyohei Egawa, Hiroshi Kawasaki, et al.
Allergy|April 2, 2024
Targeting IL-13 with tralokinumab normalizes type 2 inflammation in atopic dermatitis both early and at 2 yearsEmma Guttman-Yassky, Kenji Kabashima, Delphine Staumont-Salle, et al.
The Journal of Dermatology|May 13, 2015
Pathological characterization of pachydermia in pachydermoperiostosisKeiji Tanese, Hironori Niizeki, Atsuhito Seki, et al.
Cancer Science|September 12, 2019
Variable indoleamine 2,3-dioxygenase expression in acral/mucosal melanoma and its possible link to immunotherapyNatsuko Iga, Atsushi Otsuka, Masahiro Hirata, et al.
JAMA Dermatology|February 1, 2023
Efficacy and Safety of Dupilumab in Patients With Erythrodermic Atopic Dermatitis: A Post Hoc Analysis of 6 Randomized Clinical TrialsAmy S Paller, Jonathan I Silverberg, Michael J Cork, et al.
The Journal of Allergy and Clinical Immunology. in Practice|September 15, 2022
Magnitude and Time Course of Response to Abrocitinib for Moderate-to-Severe Atopic DermatitisKristian Reich, Peter A Lio, Robert Bissonnette, et al.
Plos One|April 14, 2021
Pollen-food allergy syndrome and component sensitization in adolescents: A Japanese population-based studyTomoyuki Kiguchi, Kiwako Yamamoto-Hanada, Mayako Saito-Abe, et al.
The Journal of Dermatology|February 3, 2025
Guidelines for the management of drug-induced hypersensitivity syndrome 2023Yoshiko Mizukawa, Natsumi Hama, Hiroyuki Niihara, et al.
Lancet (London, England)|May 23, 2021
Safety and efficacy of upadacitinib in combination with topical corticosteroids in adolescents and adults with moderate-to-severe atopic dermatitis (AD Up): results from a randomised, double-blind, placebo-controlled, phase 3 trialKristian Reich, Henrique D Teixeira, Marjolein de Bruin-Weller, et al.
Pageof 80